A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

Summary

This pilot clinical trial studies irinotecan hydrochloride in treating patients with breast cancer and brain metastases that progressed after whole brain radiation therapy or stereotactic radiosurgery. Drugs used in chemotherapy, such as irinotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Timeline

Start

2012-12

Primary completion

2017-08

Completion

2018-08

Drugs

Indications